Optimistic Investors Push Empreendimentos Pague Menos S.A. (BVMF:PGMN3) Shares Up 30% But Growth Is Lacking
Nov 27
Have your own idea? Try our Stock Screener
Brazilian (BOVESPA) Drug Retail Industry Analysis
UpdatedDec 19, 2024
DataAggregated Company Financials
Companies4
- 7D-11.5%
- 3M-17.6%
- 1Y-22.1%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 2.2%, driven by pullbacks from every company within the industry. Overall the industry is down 20% in 12 months. As for the next few years, earnings are expected to grow by 21% per annum.
Industry Valuation and Performance
Has the Brazilian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 19 Dec 2024 | R$44.3b | R$56.7b | R$1.4b | 11.6x | 31.5x | 0.8x |
| Sat, 16 Nov 2024 | R$47.2b | R$56.6b | R$1.4b | 13.6x | 33.9x | 0.8x |
| Mon, 14 Oct 2024 | R$45.2b | R$54.8b | R$1.3b | 16.5x | 36.1x | 0.8x |
| Wed, 11 Sep 2024 | R$50.7b | R$54.8b | R$1.3b | 17.2x | 40.4x | 0.9x |
| Fri, 09 Aug 2024 | R$53.2b | R$54.6b | R$1.3b | 16.4x | 42x | 1x |
| Sun, 07 Jul 2024 | R$46.9b | R$53.1b | R$1.2b | 28.7x | 38.8x | 0.9x |
| Tue, 04 Jun 2024 | R$46.5b | R$53.1b | R$1.2b | 28x | 38.4x | 0.9x |
| Thu, 02 May 2024 | R$47.4b | R$51.4b | R$1.2b | 29.8x | 40.5x | 0.9x |
| Sat, 30 Mar 2024 | R$50.6b | R$51.4b | R$1.2b | 31.9x | 43.3x | 1x |
| Mon, 26 Feb 2024 | R$48.5b | R$49.8b | R$1.1b | 19.7x | 45.8x | 1x |
| Wed, 24 Jan 2024 | R$49.4b | R$49.8b | R$1.1b | 20.4x | 46.6x | 1x |
| Fri, 22 Dec 2023 | R$53.2b | R$49.8b | R$1.1b | 21.4x | 50.3x | 1.1x |
| Sun, 19 Nov 2023 | R$51.8b | R$49.9b | R$1.1b | 20.1x | 48.9x | 1x |
| Tue, 17 Oct 2023 | R$51.1b | R$48.1b | R$948.8m | 20.1x | 53.9x | 1.1x |
| Thu, 14 Sep 2023 | R$51.7b | R$48.1b | R$948.8m | 23.1x | 54.5x | 1.1x |
| Sat, 12 Aug 2023 | R$51.0b | R$48.1b | R$1.0b | 23.1x | 49.8x | 1.1x |
| Mon, 10 Jul 2023 | R$53.0b | R$46.0b | R$1.1b | 23.4x | 49.9x | 1.2x |
| Wed, 07 Jun 2023 | R$50.8b | R$46.0b | R$1.1b | 21.2x | 47.9x | 1.1x |
| Fri, 05 May 2023 | R$46.5b | R$45.1b | R$1.1b | 17.9x | 40.6x | 1x |
| Sun, 02 Apr 2023 | R$43.3b | R$43.7b | R$1.1b | 16.6x | 39.6x | 1x |
| Tue, 28 Feb 2023 | R$40.9b | R$41.4b | R$1.0b | 30.5x | 40.4x | 1x |
| Thu, 26 Jan 2023 | R$44.8b | R$41.4b | R$1.0b | 32.5x | 44.3x | 1.1x |
| Sat, 24 Dec 2022 | R$42.9b | R$41.4b | R$1.0b | 31.3x | 42.5x | 1x |
| Mon, 21 Nov 2022 | R$42.1b | R$41.4b | R$1.0b | 31.2x | 41.6x | 1x |
| Wed, 19 Oct 2022 | R$43.0b | R$39.2b | R$1.0b | 21x | 41x | 1.1x |
| Fri, 16 Sep 2022 | R$41.5b | R$39.2b | R$1.0b | 19.1x | 39.5x | 1.1x |
| Sun, 14 Aug 2022 | R$41.3b | R$39.1b | R$1.0b | 33.7x | 39.9x | 1.1x |
| Tue, 12 Jul 2022 | R$36.2b | R$37.4b | R$945.0m | 32x | 38.3x | 1x |
| Thu, 09 Jun 2022 | R$39.7b | R$37.4b | R$945.0m | 34.6x | 42.1x | 1.1x |
| Sat, 07 May 2022 | R$36.2b | R$37.2b | R$944.3m | 32.3x | 38.4x | 1x |
| Mon, 04 Apr 2022 | R$46.5b | R$36.0b | R$997.8m | 39.9x | 46.6x | 1.3x |
| Wed, 02 Mar 2022 | R$45.3b | R$35.8b | R$1.0b | 33.2x | 44.6x | 1.3x |
| Fri, 28 Jan 2022 | R$42.5b | R$34.8b | R$1.0b | 31.2x | 42.1x | 1.2x |
| Sun, 26 Dec 2021 | R$45.6b | R$34.8b | R$1.0b | 34.5x | 45.3x | 1.3x |
Price to Earnings Ratio
45.3x
Current Industry PE
- Investors are pessimistic on the Brazilian Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 32.6x which is lower than its 3-year average PE of 43.0x.
- The 3-year average PS ratio of 1.0x is higher than the industry's current PS ratio of 0.81x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 12% per year over the last three years.
- Revenues for these companies have grown 18% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Brazilian Drug Retail compare with similar industries?
| BR Market | -7.19% | |
| Consumer Staples | -7.69% | |
| Food and Staples Retail | -13.07% | |
| Drug Retail | -11.54% | |
| Food Distributors | 0% | |
| Food Retail | -11.02% | |
| Big Box Super Stores | -15.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||
